Brazilian Expert Consensus for NTRK Gene Fusion Testing in Solid Tumors.

Oncogenic neurotrophic tropomyosin receptor kinase gene fusions occur in less than 1% of common cancers. These mutations have emerged as new biomarkers in cancer genomic profiling with the approval of selective drugs against tropomyosin receptor kinase fusion proteins. Nevertheless, the optimal path...

Descripción completa

Detalles Bibliográficos

Publicado en:	Clinical Pathology pp. 1 - 14
Autores principales:	Petaccia de Macedo, Mariana, Toledo Nascimento, Ellen Caroline, Soares, Fernando Augusto, Costa Santini, Fernando, D'Almeida Costa, Felipe, Werneck da Cunha, Isabela, Ramella Munhoz, Rodrigo, De Marchi, Pedro, Carnier Jorge, Thiago William, Ramos Moreira Leite, Kátia
Formato:	pictorial review tables/charts Journal Article
Publicado:	Sage Publications Inc. 9/15/2023
Acceso en línea:	Ver este registro en EBSCOhost